2-5 Abril 2020
Advances in Alzheimer’s and Parkinson’s Therapies, AAT-AD/PD 2020
Lugar: conferencia virtual
Póster electrónico: “Vafidemstat safety and efficacy in Alzheimer-related agitation & aggression: Phase II REIMAGINE-AD 6-month data”
Comunicación oral: “Vafidemstat in Alzheimer’s disease: initial 6-month ETHERAL data”